|
PF-26318 |
ZYRTEC 10 mg/mL.solucion oral gotas. |
2006-07-12 |
|
U.C.B. Pharma S.p.A. |
Italia
|
Smithkline Beecham Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26319 |
ZYRTEC 1 mg/mL. Jarabe |
2006-07-12 |
|
U.C.B. Pharma S.p.A. |
Italia
|
Smithkline Beecham Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-40012 |
ZYRTEC 10 mg Comprimidos Recubiertos |
2027-03-01 |
|
GlaxosmithKline Trading Services Ltd. |
Suiza
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48123 |
XUZAL 5 mg Tabletas Recubiertas |
2022-12-06 |
|
GlaxosmithKline Trading Services Ltd. |
Suiza
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26320 |
ZYRTEC 10mg. Tabletas Recubiertas |
2006-07-12 |
|
UCB Farchim, S.A. |
Suiza
|
Smithkline Beecham Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33516 |
ZYRTEC D Tabletas de liberacion prolongada |
2009-08-06 |
|
Ucb Pharma Ag |
Suiza
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50595 |
VIMPAT 10 mg/mL Solución para perfusión |
2019-09-08 |
|
UCB Pharma, S.A. |
Bélgica
|
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39416 |
KEPPRA 1000 mg Tabletas recubiertos |
2027-01-26 |
|
GlaxosmithKline Trading Services Ltd. |
Bélgica
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39419 |
KEPPRA 500 mg Tabletas recubiertas |
2027-01-26 |
|
GlaxosmithKline Trading Services Ltd. |
Bélgica
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-40769 |
ATARAX 10 mg Tabletas Recubiertas |
2023-06-23 |
|
GlaxosmithKline Trading Services Ltd. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|